Manojava Lifescience Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-07-2024
- Paid Up Capital ₹ 0.15 M
as on 02-07-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
as on 02-07-2024
- Revenue %
(FY 2022)
- Profit 65.81%
(FY 2022)
- Ebitda 63.34%
(FY 2022)
- Net Worth -100.20%
(FY 2022)
- Total Assets 450.53%
(FY 2022)
About Manojava Lifescience
The Company is engaged in the Home Appliances Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.15 M.
The company currently has active open charges totaling ₹1.00 M.
Pragalva Mohanty, Saswatimayee Mohanty, Binaya Satapathy, and One other member serve as directors at the Company.
- CIN/LLPIN
U51397OR2020PTC033745
- Company No.
033745
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Aug 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Cuttack, Odisha, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Manojava Lifescience?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mamee Prusty  | Director | 12-Aug-2020 | Current |
| Pragalva Mohanty | Additional Director | 12-Jul-2021 | Current |
| Saswatimayee Mohanty | Director | 12-Aug-2020 | Current |
| Binaya Satapathy | Director | 12-Aug-2020 | Current |
Financial Performance of Manojava Lifescience.
Manojava Lifescience Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 65.81% increase in profit. The company's net worth observed a substantial decline by a decrease of 100.2%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Manojava Lifescience?
Unlock access to Manojava Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 11 Feb 2022 | ₹1.00 M | Open |
How Many Employees Work at Manojava Lifescience?
Manojava Lifescience has a workforce of 0 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Manojava Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Manojava Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
